The Global Synthetic Biology Market was valued at USD 9.6 billion in 2021 and is estimated to grow to USD 30.8 billion in 2030, at a CAGR of 23% during the forecast period. It is predicted that demand for synthetic biology will increase due to the expanding range of applications for multiplexed diagnostics & cellular recording, as well as therapeutic genome editing. Additionally, the use of organisms and products created by synthetic biology techniques in other industries, such as the chemical and energy industries is also projected to have an impact on the market’s overall growth.
Download FREE Premium Sample of This Strategic Report: https://www.extrapolate.com/sample/Healthcare-Medical-Devices-Biotechnology/synthetic-biology-market/25964
The technique of redesigning existing organisms to carry out new roles is known as synthetic biology. It entails a multidisciplinary area of study with the goal of creating new biological devices, machinery, and systems or modifying already existing natural ones. Researchers are using synthetic biology to develop novel devices, solutions, and goods that have significant and real advantages.
Key Industry Players to Employ Strategic Collaborations to Boost Profitability
Key companies in the global synthetic biology market are employing a variety of strategies including joint ventures, mergers and acquisitions, geographic expansions, and strategic collaborations, to boost profitability. For instance, Codexis Inc. and Kalsec Inc. announced the expansion of their research partnership in July 2021 and signed a unique supply arrangement for a new enzyme to produce Kalsec’s newest natural hop acid.
Leading businesses profiled in the global Synthetic Biology include:-
- Thermo Fisher Scientific
- Merck KGaA
- Agilent Technologies, Inc.
- Novozymes A/S
- Amyris
- Precigen
- GenScript
- Twist Bioscience
- Codexis
- Synthego
- Creative Enzymes
- Eurofins Scientific
Do You Have Any Query? Ask to Our Industry Expert @ https://www.extrapolate.com/enquire/Healthcare-Medical-Devices-Biotechnology/synthetic-biology-market/25964
SEGMENTATION
By Application
- Pharmaceuticals & Diagnostics
- Chemicals
- Food & Agriculture
- Biofuels
- Others
Pharmaceuticals & Diagnostics Segment to Lead the Market Owing to its Ability to Provide Accurate Diagnostics
The pharmaceuticals & diagnostics is expected to dominate the share of the global synthetic biology market considering the fact that diagnostics provide a real-time, incredibly accurate, non-invasive way for identifying cancer cells, infectious diseases, and medications.
Researchers use rational engineering techniques to build dynamic, one-of-a-kind biosensing systems that include a sensor, processor, and reporter. Glimpse Bio has developed an activity-based biosensor to detect Non-Alcoholic Steatohepatitis (NASH) early signs, assess the severity of the ailment, and assist in the development of novel treatments.
By Product
- Enzymes
- Chassis Organisms
- Oligonucleotides & Synthetic DNA
- Cloning & Sequencing
- Xeno-Nucleic Acids
- Others
By Technology
- Genome Engineering
- Bioinformatics
- Microfluidics
- Sequencing
- Measurement and Modeling
- Nanotechnology
- Others
To buy: https://www.extrapolate.com/complete-checkout-buy/25964
Growing Applications of Synthetic Biology Globally to Drive the Market Growth
The global market for synthetic biology is growing due to the increasing applications of this technology. Numerous applications, which are expected to support market growth. Products made by utilizing synthetic biology techniques are used in a wide range of industries, including bioenergy, enzyme technology, biologically based chemicals, antibody production, and vaccine production.
Several industries employ synthetic biology to create materials and fabrics. Energy- and water-efficient textile production methods are being developed by businesses including Spiber, MacWorks, Modern Meadow, and Bolt Threads.
By Region
- North America
- Europe
- Asia-Pacific
- South America
- The Middle East and Africa
North America to Lead the Market Owing to Rising Investment for Development of Synthetic Biological Products
A substantial percentage of the global synthetic biology market share is anticipated to be dominated by North America due to favorable legislation, governmental support, and rising funding for the development of synthetic biological products. Research in the fields of proteomics, genomic structure prediction, and medication development is prioritized heavily in the United States, which benefits the synthetic biology market.
However, due to the establishment of local start-ups and participation by top companies, particularly in the biofuel sector, as well as all of the ongoing support from the European government and private groups, the Europe region is expected to experience the highest growth rate during the forecast period of the global synthetic biology market. although the existence of numerous synthetic biology centers is promoting the field.
Browse Complete Report Here: https://www.extrapolate.com/Healthcare-Medical-Devices-Biotechnology/synthetic-biology-market/25964
Recent Industry Developments –
- December 2021- For one-step quantitative reverse transcription PCR, Codexis introduced Codex® HiTemp Reverse Transcriptase (RT-qPCR).
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
Chapter 3. Market Outlook
Chapter 4. COVID-19 Impact On Synthetic Biology Market
Chapter 5. Global Synthetic Biology Market Overview, By Product, 2017 – 2030(USD Million)
Browse Complete TOC: https://www.extrapolate.com/toc/Healthcare-Medical-Devices-Biotechnology/synthetic-biology-market/25964
About Extrapolate
Extrapolate is a Global Market Research, Advisory and Consulting firm which works closely with Industry experts from various industries to bring the latest and most accurate research reports.
In an era of breakneck change and a low tolerance for missed or misread opportunities, businesses need astute guidance to shape markets – not merely respond to them. Extrapolate helps clients develop market perspectives that drive success.
Contact Us
Extrapolate
Phone: (+1) 888 328 2189
E-mail: [email protected]
Website: https://www.extrapolate.com
Blog: https://www.extrapolate.com/blog